Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1977 1
1983 1
1987 1
1991 1
2005 2
2007 2
2008 2
2009 4
2010 4
2013 2
2014 7
2015 8
2016 7
2017 5
2018 11
2019 18
2020 24
2021 23
2022 25
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
Patil VM, Noronha V, Menon N, Singh A, Ghosh-Laskar S, Budrukkar A, Bhattacharjee A, Swain M, Mathrudev V, Nawale K, Balaji A, Peelay Z, Alone M, Pathak S, Mahajan A, Kumar S, Purandare N, Agarwal A, Puranik A, Pendse S, Reddy Yallala M, Sahu H, Kapu V, Dey S, Choudhary J, Krishna MR, Shetty A, Karuvandan N, Ravind R, Rai R, Jobanputra K, Chaturvedi P, Pai PS, Chaukar D, Nair S, Thiagarajan S, Prabhash K. Patil VM, et al. Among authors: thiagarajan s. J Clin Oncol. 2023 May 1;41(13):2350-2361. doi: 10.1200/JCO.22.00980. Epub 2023 Jan 27. J Clin Oncol. 2023. PMID: 36706347 Clinical Trial.
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, Mahimkar M, Juvekar S, Arya S, Mahajan A, Agarwal A, Purandare N, Rangarajan V, Balaji A, Chaudhari SV, Banavali S, Kannan S, Bhattacharjee A, D'Cruz AK, Chaturvedi P, Pai PS, Chaukar D, Pantvaidya G, Nair D, Nair S, Deshmukh A, Thiagarajan S, Mathrudev V, Manjrekar A, Dhumal S, Maske K, Bhelekar AS, Nawale K, Chandrasekharan A, Pande N, Goel A, Talreja V, Simha V, Srinivas S, Swami R, Vallathol DH, Dsouza H, Shrirangwar S, Turkar S, Abraham G, Thanky AH, Patel U, Pandey MK, Prabhash K. Patil VM, et al. Among authors: thiagarajan s. Cancer. 2019 Sep 15;125(18):3184-3197. doi: 10.1002/cncr.32179. Epub 2019 May 31. Cancer. 2019. PMID: 31150120 Free article. Clinical Trial.
Parathyroid Carcinoma: a Review.
Sawhney S, Vaish R, Jain S, Mittal N, Ankathi SK, Thiagarajan S, Chaukar D. Sawhney S, et al. Among authors: thiagarajan s. Indian J Surg Oncol. 2022 Mar;13(1):133-142. doi: 10.1007/s13193-021-01343-3. Epub 2021 Jun 3. Indian J Surg Oncol. 2022. PMID: 35462650 Free PMC article. Review.
Resolution of acute intestinal graft-versus-host disease.
Thiagarajan S, Neurath MF, Hildner K. Thiagarajan S, et al. Semin Immunopathol. 2019 Nov;41(6):655-664. doi: 10.1007/s00281-019-00769-w. Epub 2019 Oct 31. Semin Immunopathol. 2019. PMID: 31673757 Review.
Oral manifestations of mpox (monkeypox).
Thiagarajan SV, Brooks JK, Sultan AS. Thiagarajan SV, et al. Gen Dent. 2024 Mar-Apr;72(2):30-37. Gen Dent. 2024. PMID: 38411483
Ameloblastoma variant.
Narasimhan M, Thiagarajan S, Chinnaswami R, Ranganathan S, Hari T. Narasimhan M, et al. Among authors: thiagarajan s. J Clin Diagn Res. 2014 Sep;8(9):ZL01. doi: 10.7860/JCDR/2014/9227.4834. Epub 2014 Sep 20. J Clin Diagn Res. 2014. PMID: 25386551 Free PMC article. No abstract available.
The Authors Respond.
Manadan AM, Mathur T, Thiagarajan S, Hota B, Block JA. Manadan AM, et al. Among authors: thiagarajan s. J Clin Rheumatol. 2015 Oct;21(7):389. doi: 10.1097/RHU.0000000000000314. J Clin Rheumatol. 2015. PMID: 26398475 No abstract available.
150 results